236 related articles for article (PubMed ID: 19595309)
21. Inhibition of human sirtuins by in situ generation of an acetylated lysine-ADP-ribose conjugate.
Asaba T; Suzuki T; Ueda R; Tsumoto H; Nakagawa H; Miyata N
J Am Chem Soc; 2009 May; 131(20):6989-96. PubMed ID: 19413317
[TBL] [Abstract][Full Text] [Related]
22. SIRT1: linking adaptive cellular responses to aging-associated changes in organismal physiology.
Anastasiou D; Krek W
Physiology (Bethesda); 2006 Dec; 21():404-10. PubMed ID: 17119153
[TBL] [Abstract][Full Text] [Related]
23. Sirtuin 1 (SIRT1): the misunderstood HDAC.
Stünkel W; Campbell RM
J Biomol Screen; 2011 Dec; 16(10):1153-69. PubMed ID: 22086720
[TBL] [Abstract][Full Text] [Related]
24. Loss of one p53 allele results in four-fold reduction of p53 mRNA and protein: a basis for p53 haplo-insufficiency.
Lynch CJ; Milner J
Oncogene; 2006 Jun; 25(24):3463-70. PubMed ID: 16449974
[TBL] [Abstract][Full Text] [Related]
25. SIRTUIN 1: regulating the regulator.
Zschoernig B; Mahlknecht U
Biochem Biophys Res Commun; 2008 Nov; 376(2):251-5. PubMed ID: 18774777
[TBL] [Abstract][Full Text] [Related]
26. [Sirtuins--modulation of their activity as a novel therapeutic target].
Kucińska M; Piotrowska H; Murias M
Pol Merkur Lekarski; 2010 Mar; 28(165):231-5. PubMed ID: 20815175
[TBL] [Abstract][Full Text] [Related]
27. Therapeutic potential of activators and inhibitors of sirtuins.
Balcerczyk A; Pirola L
Biofactors; 2010; 36(5):383-93. PubMed ID: 20848588
[TBL] [Abstract][Full Text] [Related]
28. The Sirtuin family: therapeutic targets to treat diseases of aging.
Milne JC; Denu JM
Curr Opin Chem Biol; 2008 Feb; 12(1):11-7. PubMed ID: 18282481
[TBL] [Abstract][Full Text] [Related]
29. Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice.
Cheng HL; Mostoslavsky R; Saito S; Manis JP; Gu Y; Patel P; Bronson R; Appella E; Alt FW; Chua KF
Proc Natl Acad Sci U S A; 2003 Sep; 100(19):10794-9. PubMed ID: 12960381
[TBL] [Abstract][Full Text] [Related]
30. Identification and characterization of proteins interacting with SIRT1 and SIRT3: implications in the anti-aging and metabolic effects of sirtuins.
Law IK; Liu L; Xu A; Lam KS; Vanhoutte PM; Che CM; Leung PT; Wang Y
Proteomics; 2009 May; 9(9):2444-56. PubMed ID: 19343720
[TBL] [Abstract][Full Text] [Related]
31. sirt1-null mice develop an autoimmune-like condition.
Sequeira J; Boily G; Bazinet S; Saliba S; He X; Jardine K; Kennedy C; Staines W; Rousseaux C; Mueller R; McBurney MW
Exp Cell Res; 2008 Oct; 314(16):3069-74. PubMed ID: 18687325
[TBL] [Abstract][Full Text] [Related]
32. A therapeutic role for sirtuins in diseases of aging?
Westphal CH; Dipp MA; Guarente L
Trends Biochem Sci; 2007 Dec; 32(12):555-60. PubMed ID: 17980602
[TBL] [Abstract][Full Text] [Related]
33. Sirtuins as novel targets for Alzheimer's disease and other neurodegenerative disorders: experimental and genetic evidence.
Albani D; Polito L; Forloni G
J Alzheimers Dis; 2010; 19(1):11-26. PubMed ID: 20061622
[TBL] [Abstract][Full Text] [Related]
34. Function of sirtuins in biological tissues.
Shoba B; Lwin ZM; Ling LS; Bay BH; Yip GW; Kumar SD
Anat Rec (Hoboken); 2009 Apr; 292(4):536-43. PubMed ID: 19301279
[TBL] [Abstract][Full Text] [Related]
35. Sirt7-dependent inhibition of cell growth and proliferation might be instrumental to mediate tissue integrity during aging.
Vakhrusheva O; Braeuer D; Liu Z; Braun T; Bober E
J Physiol Pharmacol; 2008 Dec; 59 Suppl 9():201-12. PubMed ID: 19261981
[TBL] [Abstract][Full Text] [Related]
36. Mechanism-based inhibition of Sir2 deacetylases by thioacetyl-lysine peptide.
Smith BC; Denu JM
Biochemistry; 2007 Dec; 46(50):14478-86. PubMed ID: 18027980
[TBL] [Abstract][Full Text] [Related]
37. How does SIRT1 affect metabolism, senescence and cancer?
Brooks CL; Gu W
Nat Rev Cancer; 2009 Feb; 9(2):123-8. PubMed ID: 19132007
[TBL] [Abstract][Full Text] [Related]
38. Molecular cloning and characterization of porcine sirtuin genes.
Jin D; Tan HJ; Lei T; Gan L; Chen XD; Long QQ; Feng B; Yang ZQ
Comp Biochem Physiol B Biochem Mol Biol; 2009 Aug; 153(4):348-58. PubMed ID: 19389481
[TBL] [Abstract][Full Text] [Related]
39. TR-FRET biochemical assays for detecting posttranslational modifications of p53.
Dudek JM; Horton RA
J Biomol Screen; 2010 Jun; 15(5):569-75. PubMed ID: 20400726
[TBL] [Abstract][Full Text] [Related]
40. SIRT1: regulation of longevity via autophagy.
Salminen A; Kaarniranta K
Cell Signal; 2009 Sep; 21(9):1356-60. PubMed ID: 19249351
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
